Shared promoter elements between a viral superantigen and the major histocompatibility complex class II-associated invariant chain

Journal of Virology

Volumn 71, Issue 2, 1997, Pages 1237-1245

  Arroyo, Juan ^a   Winchester, Ellen ^a   McLellan, Brian S ^a   Huber, Brigitte T ^a,b  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIRUS ANTIGEN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; GENE EXPRESSION REGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; VIRUS EXPRESSION; VIRUS TRANSMISSION;

EID: 0031014703     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.2.1237-1245.1997     Document Type: Article

References (71)

1. Acha-Orbea, H., and H. R. MacDonald. 1995. Superantigens of mouse mammary tumor virus. Annu. Rev. Immunol. 13:459-486.
2. Acha-Orbea, H. (Ludwig Institute, Lausanne, Switzerland). Personal communication.
3. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, and J. A. Smith. 1995. Current protocols in molecular biology, p. 4.8.2. John Wiley & Sons. Inc., Boston, Mass.
4. Basta, P. V., P. A. Sherman, and J. P. Ting. 1988. Detailed delineation of an interferon-gamma-responsive element important in human HLA-DRA gene expression in a glioblastoma multiform line. Proc. Natl. Acad. Sci. USA 85:8618-8622.
5. Beutner, U., W. N. Frankel, M. S. Cote, J. M. Coffin, and B. T. Huber. 1992. Mls-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7. Proc. Natl. Acad. Sci. USA 89:5432-5436.
6. Beutner, U., and B. T. Huber. Unpublished observation.
7. Beutner, U., E. Kraus, D. Kitamura, K. Rajewsky, and B. T. Huber. 1994. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. J. Exp. Med. 179:1457-1466.
8. Brown, A. M., K. L. Wright, and J. P. Ting. 1993. Human major histocompatibility complex class II-associated invariant chain gene promoter. Functional analysis and in vivo protein/DNA interactions of constitutive and IFN-gamma-induced expression. J. Biol. Chem. 268:26328-26333.
9. Buetti, E. 1994. Stably integrated mouse mammary tumor virus long terminal repeat DNA requires the octamer motifs for basal promoter activity. Mol. Cell. Biol. 14:1191-1203.
10. Cavin, C., and E. Buetti. 1995. Tissue-specific and ubiquitous factors binding next to the glucocorticoid receptor modulate transcription from the mouse mammary tumor virus promoter. J. Virol. 69:3759-3770.
11. Cresswell, P. 1994. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12:259-293.
12. Chang, C.-H., S. Guerder, S.-C. Hong, W. van Ewijk, and R. A. Flavell. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4:167-178.
13. Corley, R. B., F. E. Lund, T. D. Randall, L. B. King, S. Doerre, and D. L. Woodland. 1992. Mouse mammary tumor proviral gene expression in cells of the B lineage. Semin. Immunol. 4:287-296.
14. Darnell, J. J., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421. (Review.)
15. Dellabona, P., J. Peccoud, J. Kappler, P. Marrack, C. Benoist, and D. Mathis. 1990. Superantigens interact with MHC class II molecules outside of the antigen groove. Cell 62:1115-1121.
16. Dyson, P. J., A. M. Knight, S. Fairchild, E. Simpson, and K. Tomonari. 1991. Genes encoding ligands for deletion of V beta 11 T cells cosegregate with mammary tumour virus genomes. Nature 349:531-532.
17. Eades, A. M., M. Litfin, and H. J. Rahmsdorf. 1990. The IFN-gamma response of the murine invariant chain gene is mediated by a complex enhancer that includes several MHC class II consensus elements. J. Immunol. 144:4399-4409.
18. Farrar, J. J., J. Fuller-Farrar, P. L. Simon, M. L. Hilfiker, B. M. Stadler, and W. L. Farrar. 1980. Thymoma production of T cell growth factor (interleukin 2). J. Immunol. 125:2555-2558.
19. Festenstein, H. 1973. Immunogenetic and biological aspects of in vitro lymphocyte allotransformation (MLR) in the mouse. Transplant. Rev. 15:62-88.
20. Fleischer, B., and H. Schrezenmeir. 1988. T cell stimulation by Staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells. J. Exp. Med. 167:1697-1707.
21. Frankel, W. N., C. Rudy, J. M. Coffin, and B. T. Huber. 1991. Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice. Nature 349: 526-528.
22. Glimcher, L. H., and C. J. Kara. 1992. Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 10:13-49.
23. Golovkina, T. V., A. Chervonsky, J. P. Dudley, and S. R. Ross. 1992. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell 69:637-645.
24. Gunzburg, W. H., F. Heinemann, S. Wintersperger, T. Miethke, H. Wagner, V. Erfle, and B. Salmons. 1993. Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat. Nature 364:154-158.
25. Gunzburg, W. H., and B. Salmons. 1992. Factors controlling the expression of mouse mammary tumour virus. Biochem. J. 283:625-632.
26. Held, W., A. N. Shakhov, S. Izui, G. A. Waanders, L. Scarpellino, H. R. MacDonald, and H. Acha-Orbea. 1993. Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus. J. Exp. Med. 177:359-366.
27. Held, W., A. N. Shakhov, G. Waanders, L. Scarpellino, R. Luethy, J. P. Kraehenbuhl, H. R. MacDonald, and H. Acha-Orbea. 1992. An exogenous mouse mammary tumor virus with properties of Mls-1a (Mtv-7). J. Exp. Med. 175:1623-1633.
28. Held, W., G. A. Waanders, A. N. Shakhow, L. Scarpellino, H. Acha-Orbea, and H. R. MacDonald. 1993. Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell 74:529-540.
29. Herman, A., G. Croteau, R. P. Sekaly, J. Kappler, and P. Marrack. 1990. HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells. J. Exp. Med. 172:709-717.
30. Hsu, P.-N., P. Wolf, B. McLellan, H. Ploegh, and B. T. Huber. Association of viral superantigen with MHC class II during biosynthesis. Submitted for publication.
31. Hyman, R., and V. Stalling. 1974. Complementation patterns of Thy-1 variants and evidence that antigen loss variants "pre-exist" in the parental population. Natl. Cancer Inst. 52:429-136.
32. Jainchill, J. L., S. A. Aaronson, and G. J. Todaro. 1969. Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells. J. Virol. 4:549-553.
33. Kappler, J. W., U. Staerz, J. White, and P. C. Marrack. 1988. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Nature 332:35-40.
34. Kim, K. J., C. Kanellopoulos-Langevin, R. M. Merwin, D. H. Sachs, and R. Asofsky. 1979. Establishment and characterization of BALB/c lymphoma lines with B cell properties. J. Immunol. 122:549-554.
35. Landolfi, N. F., X. M. Yin, J. D. Capra, and P. W. Tucker. 1988. A conserved heptamer upstream of the IgH promoter region octamer can be the site of a coordinate protein-DNA interaction. Nucleic Acids Res. 16:5503-5514.
36. Laskov, R., and M. D. Scharff. 1970. Synthesis, assembly, and secretion of gamma globulin by mouse myeloma cells. I. Adaptation of the Merwin plasma cell tumor-11 to culture, cloning, and characterization of gamma globulin subunits. J. Exp. Med. 131:515-541.
37. Lechler, R. I., V. Bal, J. B. Rothbard, R. N. Germain, R. Sekaly, E. O. Long, and J. Lamb. 1988. Structural and functional studies of HLA-DR restricted antigen recognition by human helper T lymphocyte clones by using transfected murine cell lines. J. Immunol. 141:3003-3009.
38. Lund, F. E., and R. B. Corley. 1991. Regulated expression of mouse mammary tumor proviral genes in cells of the B lineage. J. Exp. Med. 174:1439-1450.
39. Luo, Y., H. Fujii, T. Gerster, and R. G. Roeder. 1992. A novel B cell-derived coactivator potentiates the activation of immunoglobulin promoters by octamer-binding transcription factors. Cell 71:231-241.
40. Luo, Y., and R. G. Roeder. 1995. Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B. Mol. Cell. Biol. 15:4115-4124.
41. MacDonald, H. R., R. Schneider, R. K. Lees, R. C. Howe, H. Acha-Orbea, H. Festenstein, R. M. Zinkernagel, and H. Hengartner. 1988. T-cell receptor V beta use predicts reactivity and tolerance to Mlsa-encoded antigens. Nature 332:40-45.
42. Marrack, P., E. Kushnir, and J. Kappler. 1991. A maternally inherited superantigen encoded by a mammary tumour virus. Nature 349:524-526.
43. Mellins, E., L. Smith, B. Arp, T. Cotner, E. Celis, and D. Pious. 1990. Detective processing and presentation of exogenous antigens in mutants with normal HLA class II genes. Nature 343:71-74.
44. Miller, C. L., R. Garner, and V. Paetkau. 1992. An activation-dependent, T-lymphocyte-specific transcriptional activator in the mouse mammary tumor virus env gene. Mol. Cell. Biol. 12:3262-3272.
45. Moore, R., M. Dixon, R. Smith, G. Peters, and C. Dickson. 1987. Complete nucleotide sequence of a milk-transmitted mouse mammary tumor virus: two frameshift suppression events are required for translation of gag and pol. J. Virol. 61:480-490.
46. Morishima, C., C. Norby-Slycord, K. R. McConnell, R. J. Finch, A. J. Nelson, A. G. Farr, and A. M. Pullen. 1994. Expression of two structurally identical viral superantigens results in thymic elimination at distinct developmental stages. J. Immunol. 153:5091-5103.
47. Mows, C. C., T. Preiss, E. P. Slater, X. Cao, C. P. Verrijzer, P. C. van Der Vliet, and M. Beato. 1994. Two independent pathways for transcription from the MMTV promoter. J. Steroid Biochem. Mol. Biol. 51:21-32.
48. Nakshatri, H., P. Nakshatri, and R. A. Currie. 1995. Interaction of Oct-1 with TFIIB. Implications for a novel response elicited through the proximal octamer site of the lipoprotein lipase promoter. J. Biol. Chem. 270:19613-19623.
49. Nicolas, J. F., D. Wegmann, P. Lebrun, D. Kaiserlian, J. Tovey, and A. Glasebrook. 1987. Relationship of B cell Fc receptors to T cell recognition of Mls antigen. Eur. J. Immunol. 17:1561-1565.
50. Outram, S. V., and M. J. Owen. 1994. The helix-loop-helix containing transcription factor USF activates the promoter of the CD2 gene. J. Biol. Chem. 269:26525-26530.
51. Reimold, A. M., P. D. Ponath, Y.-S. Li, R. R. Hardy, C. S. David, J. L. Strominger, and L. H. Glimcher. 1996. Transcription factor B cell lineagespecific activator protein regulates the gene for human X-box binding protein 1. J. Exp. Med. 183:393-401.
52. Reith, W., C. A. Siegrist, B. Durand, E. Barras, and B. Mach. 1994. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl. Acad. Sci. USA 91: 554-558.
53. Riley, J. L., S. D. Westerheide, J. A. Price, J. A. Brown, and J. M. Boss. 1995. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2:533-543.
54. Rudy, C. K., E. Kraus, E. Palmer, and B. T. Huber. 1992. Mls-1-like superantigen in the MA/MyJ mouse is encoded by a new mammary tumor provirus that is distinct from Mtv-7. J. Exp. Med. 175:1613-1621.
55. Ryffel, G. U., W. Kugler, U. Wagner, and M. Kaling. 1989. Liver cell specific gene transcription in vitro: the promoter elements HP1 and TATA box are necessary and sufficient to generate a liver-specific promoter. Nucleic Acids Res. 17:939-953.
56. Sarkar, N. H., S. Haga, A. F. Lehner, W. Zhao, S. Imai, and K. Moriwaki. 1994. Insertional mutation of int protooncogenes in the mammary tumors of a new strain of mice derived from the wild in China: normal- and tumor-tissue-specific expression of int-3 transcripts. Virology 203:52-62.
57. Seed, B., and A. Aruffo. 1987. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc. Natl. Acad. Sci. USA 84:3365-3369.
58. Showe, M. K., D. L. Williams, and L. C. Snowe. 1992. Quantitation of transient gene expression after electroporation. Nucleic Acids Res. 20:3153-3157.
59. Tanaka, M., W. M. Clouston, and W. Herr. 1994. The Oct-2 glutamine-rich and proline-rich activation domains can synergize with each other or duplicates of themselves to activate transcription. Mol. Cell. Biol. 14:6046-6055.
60. Truss, M., R. Candau, S. Chavez, and M. Beato. 1995. Transcriptional control by steroid hormones: the role of chromatin. Ciba Found. Symp. 191:7-23.
61. Tsang, S. Y., M. Nakanishi, and B. M. Peterlin. 1988. B-cell-specific and interferon-gamma-inducible regulation of the HLA-DR alpha gene. Proc. Natl. Acad. Sci. USA 85:8598-8602.
62. Verrijzer, C. P., J. A. van Oosterhout, and P. C. van der Vliet. 1992. The Oct-1 POU domain mediates interactions between Oct-1 and other POU proteins. Mol. Cell. Biol. 12:542-551.
63. Waanders, G. A., R. K. Lees, W. Held, and H. R. MacDonald. 1995. Quantitation of endogenous mouse mammary tumor virus superantigen expression by lymphocyte subsets. Eur. J. Immunol. 25:2632-2637.
64. Wen. Z., Z. Zhong, and J. J. Darnell. 1995. Maximal activation of transcription by Stall and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241-250.
65. White, J., A. Herman, A. M. Pullen, R. Kubo, J. W. Kappler, and P. Marrack. 1989. The Vβ-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56:27-35.
66. Winslow, G. M., P. Marrack, and J. W. Kappler. 1994. Processing and major histocompatibility complex binding of the MTV7 superantigen. Immunity 1:23-33.
67. Woodland, D. L., M. P. Happ, K. J. Gollob, and E. Palmer. 1991 An endogenous retrovirus mediating deletion of alpha beta T cells? Nature 349:529-530.
68. Wright, K. L. (University of North Carolina, Chapel Hill). Personal communication.
69. Wright, K. L., T. L. Moore, B. J. Vilen, A. M. Brown, and J. P. Ting. 1995. Major histocompatibility complex class II-associated invariant chain gene expression is up-regulated by cooperative interactions of Sp1 and NF-Y. J. Biol. Chem. 270:20978-20986.
70. Xu, L., S. Haga, S. Imai, and N. H. Sarkar. 1994. Cloning in a plasmid of an MMTV from a wild Chinese mouse: sequencing of the viral LTR. Virus Res. 33:167-178.
71. Xu, L., T. J. Wrona, and J. P. Dudley. 1996. Exogenous mouse mammary tumor virus (MMTV) infection induces endogenous MMTV sag expression. Virology 215:113-123.